生命科学资讯

FDA to remove some monkey testing from monoclonal antibody development

Tech emerges as a new frontier for digital therapeutics

ARCH, Parker Institute build next big oncology bet with suite of programs and startup acquisition

Top drug regulator Rick Pazdur plans to leave FDA

Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug

As approval date looms, Cytokinetics gears up for David-and-Goliath battle with Bristol Myers

Helicore stops work on clinical GIP antagonist after Phase 1 results

Trial Library raises $10M to sell clinical trial matching to insurers

Imvax shares Phase 2b data for glioblastoma treatment, plans to meet with FDA

Vandria plots Series B raise to advance Alzheimer’s drug into Phase 2

House passes bill to reauthorize rare pediatric PRV program; Senate next

New ACIP chair claims Covid-19 vaccines caused cancer, miscarriages

Janux’s prostate cancer immunotherapy’s response rate drops, according to new early-stage data

FDA and Prasad's Covid vaccine death claims lack key details

Belite Bio aims for first approval of Stargardt disease treatment with Phase 3 success

UK to spend more on medicines for US tariff exemption

Angelini, European Investment Bank join forces; Radiopharma startup raises $40M

Lilly slightly lowers self-pay prices for single-dose vials of Zepbound

Biopharma Sentiment Index | Q4 2025

"Heavy AI" is taking over biopharma | Signal Pulse Report